1. Home
  2. FNWB vs PMVP Comparison

FNWB vs PMVP Comparison

Compare FNWB & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

N/A

Current Price

$9.08

Market Cap

79.8M

Sector

Finance

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.33

Market Cap

79.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
PMVP
Founded
1923
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.8M
79.5M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
FNWB
PMVP
Price
$9.08
$1.33
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
34.5K
455.5K
Earning Date
04-23-2026
03-06-2026
Dividend Yield
0.80%
N/A
EPS Growth
36.00
N/A
EPS
N/A
N/A
Revenue
$176,000.00
N/A
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$0.82
52 Week High
$10.98
$1.88

Technical Indicators

Market Signals
Indicator
FNWB
PMVP
Relative Strength Index (RSI) 47.64 47.07
Support Level $7.56 $1.26
Resistance Level $9.00 $1.39
Average True Range (ATR) 0.29 0.07
MACD 0.05 -0.04
Stochastic Oscillator 67.28 34.62

Price Performance

Historical Comparison
FNWB
PMVP

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: